GGrantIndex
← Leaderboards

David H Johnson

Vanderbilt University

$5,849,161
Attributed
$5,849,161
Total exposure
4
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $889.5K · FY200511
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11

Funding mix

By agency

NIH$5,849,161 · 4

By mechanism

U10$4,094,708 · 1
P50$1,080,372 · 2
T32$674,081 · 1

Top collaborators

No co-investigators on record.

Most similar at Vanderbilt University

Same institution · by research overlap

Others in their field

Top investigators on “Human Subject

Research focus

Human SubjectClinical TrialsNeoplasm /Cancer ChemotherapyNeoplasm /Cancer GeneticsCancer PatientTumorReportingMalignant NeoplasmsPathologyLeukemiaFigs - DietaryProgramsAngiogenesisResearch PersonnelChemotherapyClinical ResearchAntineoplasticsFundingGrantGrowthPrincipal InvestigatorHuman Therapy EvaluationNeoplasm /Cancer Radiation TherapyNeoplasm /Cancer Surgery

Grant awards (21)

EICOSANOID PATHWAY TARGETS IN LUNG CANCER$207,943
P50 · FY2011 · CA · contact PI
EICOSANOID PATHWAY TARGETS IN LUNG CANCER$219,591
P50 · FY2010 · CA · contact PI
Eastern Cooperative Oncology Group$362,155
U10 · FY2009 · CA · contact PI
Vanderbilt Training Program in Academic Cancer Research$258,839
T32 · FY2009 · CA · contact PI
EICOSANOID PATHWAY TARGETS IN LUNG CANCER$220,309
P50 · FY2009 · CA · contact PI
Eastern Cooperative Oncology Group$390,865
U10 · FY2008 · CA · contact PI
Vanderbilt Training Program in Academic Cancer Research$277,614
T32 · FY2008 · CA · contact PI
EICOSANOID PATHWAY TARGETS IN LUNG CANCER$221,036
P50 · FY2008 · CA · contact PI
Eastern Cooperative Oncology Group$390,329
U10 · FY2007 · CA · contact PI
EICOSANOID PATHWAY TARGETS IN LUNG CANCER$211,493
P50 · FY2007 · CA · contact PI
Vanderbilt Training Program in Academic Cancer Research$137,628
T32 · FY2007 · CA · contact PI
Eastern Cooperative Oncology Group$387,793
U10 · FY2006 · CA · contact PI
Eastern Cooperative Oncology Group$426,296
U10 · FY2005 · CA
Eastern Cooperative Oncology Group$436,068
U10 · FY2004 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP$430,690
U10 · FY2003 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP$435,349
U10 · FY2002 · CA
ROLE OF COX2 IN LUNG CANCER ANGIOGENESIS AND METASTASIS$0
P50 · FY2002 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP$422,042
U10 · FY2001 · CA
ROLE OF COX2 IN LUNG CANCER ANGIOGENESIS AND METASTASIS$0
P50 · FY2001 · CA
ROLE OF COX2 IN LUNG CANCER ANGIOGENESIS AND METASTASIS$0
P50 · FY2001 · CA
EASTERN COOPERATIVE ONCOLOGY GROUP$413,121
U10 · FY2000 · CA